Is low-dose naltrexone for fibromyalgia another treatment disappointment?

Lancet Rheumatol. 2024 Jan;6(1):e5-e6. doi: 10.1016/S2665-9913(23)00297-7. Epub 2023 Dec 5.

Authors

Winfried Häuser¹, Mary-Ann Fitzcharles²

Affiliations

¹ Center for Pain Medicine and Mental Health, Saarbrücken D-66111 Saarbrücken, Germany; Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany. Electronic address: winfriedhaeuser@googlemail.com.
² Alan Edwards Pain Management Unit and Division of Rheumatology, McGill University Health Centre, Montreal, QC, Canada.

PMID: 38258679
DOI: 10.1016/S2665-9913(23)00297-7

No abstract available

MeSH terms

Fibromyalgia* / drug therapy
Humans
Naltrexone / therapeutic use

Substances

Naltrexone